Moneycontrol Be a Pro
Get App
Last Updated : Nov 05, 2015 12:15 PM IST | Source: CNBC-TV18

Sell Ceat, HDIL, IRB Infra, Aurobindo Pharma: Rakesh Bansal

Rakesh Bansal of RK Global recommends selling Ceat, HDIL, IRB Infra and Aurobindo Pharma.

In CNBC-TV18's popular show Bull's Eye, Rakesh Bansal of RK Global shares trading strategy of the day.

In yesterday's trading session, we have seen a fresh breakdown on the charts of Ceat. Now its charts are making lower tops and lower bottoms, in fact we have seen a negative crossover on the momentum indicator. With two-three days perspective sell Ceat at current level with a stop loss at Rs 1,100, for a target price of Rs 1,020.

In HDIL, on yesterday's trading session, we have seen a negative crossover on the momentum indicators as well as on indicator sell also. Technical structure is extremely bearish, the stock is making lower tops and lower bottoms, I am of the opinion that one can sell HDIL at current level with one-two days perspective with a stop loss at Rs 72.20 for a target price of Rs 65.30.

In yesterday's trading session, we have seen a fresh crack on charts of IRB Infra below Rs 245. Now the stock charts are making lower tops and lower bottoms. One can sell IRB Infra at current level with stop loss at Rs 253 for a target price of Rs 225.

Ahead of the results we have seen a crack on the charts of Aurobindo Pharma. The stock chart is making lower tops and lower bottoms. We have seen a negative crossover on the momentum indicators. Sell Aurobindo Pharma at current level with a stop loss at Rs 845 for a target price of Rs 780.



Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.
First Published on Nov 5, 2015 12:15 pm
Loading...
Sections
Follow us on
Available On